LIQUID PHARMACEUTICAL COMPOSITIONS COMPRISING SGLT-2 INHIBITORS

To provide a novel pharmaceutical composition comprising at least one SGLT-2 inhibitor.SOLUTION: A liquid pharmaceutical composition comprising at least one SGLT-2 inhibitor and one or more polar organic solvents, wherein the at least one SGLT-2 inhibitor comprises 1-cyano-2-(4-cyclopropyl-benzyl)-4...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	PRIDDY TIMOTHY SHANE, THOMAS ADAM DUCH, HEIKE STETTLER, MARBOD HAASE, CLAUDIUS WEILER
Format:	Patent
Sprache:	eng ; jpn
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	To provide a novel pharmaceutical composition comprising at least one SGLT-2 inhibitor.SOLUTION: A liquid pharmaceutical composition comprising at least one SGLT-2 inhibitor and one or more polar organic solvents, wherein the at least one SGLT-2 inhibitor comprises 1-cyano-2-(4-cyclopropyl-benzyl)-4-(β-D-glucopyranos-1-yl)-benzene according to formula (I), as well as corresponding processes of manufacturing such liquid pharmaceutical compositions and their medical uses.SELECTED DRAWING: None 【課題】本発明は、少なくとも１つのSGLT-2阻害剤を含む新規な医薬組成物を提供する。【解決手段】本発明は、少なくとも１つのSGLT-2阻害剤および１つ以上の極性有機溶媒を含む新規な液体医薬組成物であって、少なくとも１つのSGLT-2阻害剤が式(I)に従う1-シアノ-2-(4-シクロプロピル-ベンジル)-4-(β-D-グルコピラノス-1-イル)-ベンゼンを含んでいる、前記液体医薬組成物ならびに該液体医薬組成物の対応する製造方法およびその医学的使用に関する。(I)【選択図】なし